
Alice Yu, MD, PhD
Principal Investigator
Dr. Yu’s has more than 40 years of experience in developing cures and understanding the biology of childhood cancer research, has pioneered anti-GD2 therapy, and has either led or significantly contributed in numerous clinical trials to bring novel cancer therapeutics to market. Read more.